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AbstrACt 
Introduction The number of new paediatric infections per 
year has declined in sub-Saharan Africa due to prevention-
of-mother-to-child HIV transmission programmes; 
many children and adolescents living with HIV remain 
undiagnosed. In this protocol paper, we describe the 
methodology for evaluating an index-linked HIV testing 
approach for children aged 2–18 years in health facility 
and community settings in Zimbabwe.
Methods and analysis Individuals attending for HIV 
care at selected primary healthcare clinics (PHCs) will 
be asked if they have any children aged 2–18 years in 
their households who have not been tested for HIV. Three 
options for HIV testing for these children will be offered: 
testing at the PHC; home-based testing performed by 
community workers; or an oral mucosal HIV test given 
to the caregiver to test the children at home. All eligible 
children will be followed-up to ascertain whether HIV 
testing occurred. For those who did not test, reasons 
will be determined, and for those who tested, the HIV 
test result will be recorded. The primary outcome will be 
uptake of HIV testing. The secondary outcomes will be 
preferred HIV testing method, HIV yield, prevalence and 
proportion of those testing positive linking to care and 
having an undetectable viral load at 12 months. HIV test 
results will be stratified by sex and age group, and factors 
associated with uptake of HIV testing and choice of HIV 
testing method will be investigated.
Ethics and dissemination Ethical approval for this 
study was granted by the Medical Research Council of 
Zimbabwe, the London School of Hygiene and Tropical 
Medicine and the Institutional Review Board of the 
Biomedical Research and Training Institute. Study results 
will be presented at national policy meetings and national 
and international research conferences. Results will also 
be published in international peer-reviewed scientific 
journals and disseminated to study communities at the 
end of study.
IntroduCtIon
HIV testing is the critical first step to accessing 
life-saving antiretroviral therapy (ART).1 
Despite this, many children living with HIV 
in sub-Saharan Africa, which was home to 
approximately 92% of the 3.2 million chil-
dren below 15 years with HIV globally in 
2014, remain undiagnosed.2–4 
Children infected through mother-to-
child transmission who are not diagnosed 
in infancy often remain undiagnosed until 
strengths and limitations of this study
 ► Our study will provide evidence for the effective-
ness of index-linked HIV testing in facilities and 
communities. The strategy has the potential to be a 
cost-effective and efficient strategy for HIV testing in 
children, given the relatively low prevalence in this 
age group.
 ► Our intervention is relevant to policy questions for 
the implementation of HIV testing for children. This 
study will provide evidence for use of lower level 
cadres to offer and perform HIV testing as advocated 
by the WHO in both rural and urban settings.
 ► Other HIV testing interventions will be implemented 
by other stakeholders in the study areas during the 
study period. This may affect the impact  assess-
ment of this study.
 ► Potential challenges include low uptake of the inter-
vention, lost-to-follow-up of clients once they have 
agreed to have their child tested and finding clients 
who have opted for home-based testing.
 ► Due to relatively low HIV prevalence (<4%), analysis 
of linkage to care will be limited to a purely descrip-
tive analysis of the proportion of children linking to 
care and virologically suppressed at 12 months.
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they present with symptomatic HIV infection in later 
childhood.5 Coverage of early infant diagnosis is subop-
timal and therefore a substantial proportion of children 
infected through mother-to-child transmission are not 
diagnosed timely in infancy and are only identified in 
later childhood when they develop advanced disease.6 
In 2017, only 63% of HIV-exposed infants in eastern 
and southern Africa received an HIV test within 8 weeks 
of age as recommended.6 In a study that implemented 
provider-initiated HIV testing and counselling (PITC) 
among children aged 6–16 years in primary care clinics 
in Zimbabwe from 2013 to 2015, the median age of HIV 
diagnosis was 11 years and those aged >13 years were 
less likely than younger children to be diagnosed.7 8 The 
high proportion of undiagnosed HIV among children in 
sub-Saharan Africa, together with low paediatric treat-
ment coverage, continues to be key in sustaining the 
epidemic.
Barriers to HIV testing of children and adolescents 
include the need for guardian consent in most countries 
in sub-Saharan Africa for children younger than 16 years, 
negative attitudes and lack of training among healthcare 
workers, stigma and long distances between homes and 
healthcare facilities where testing is provided, inconve-
nient opening hours of facilities and long waiting times.1
A 2011 study from Zambia assessing reasons for non-up-
take of HIV testing among children aged below 15 
years found that the majority (76%) with confirmed or 
suspected HIV infection had a primary caregiver who was 
also living with HIV.9 A study from Zimbabwe testing chil-
dren aged 6–16 years conducted in 2014 found that 95% 
of those who tested HIV positive were perinatally infected. 
More importantly, 65% had a caregiver or sibling known 
to be HIV positive or taking ART, and 20% of the accom-
panying caregivers also tested HIV positive.10 Similarly, 
in a Malawian study including patients (15–49 years) on 
ART at a large ART clinic in 2006–2007, 81% of their 
children (0–16 years) had reportedly not been tested.11 
These studies show that children living with HIV-infected 
adults are at high risk for being HIV positive themselves; 
however, in most instances, these children have not been 
provided with HIV testing.
The WHO has recommended index-linked HIV testing, 
whereby household members, sexual contacts or children 
of a known HIV-infected person are offered an HIV test, 
as one of the approaches for addressing the gap in HIV 
testing.12 Two studies that have implemented such an 
approach among children in Malawi and Kenya found 
that more than 40% of adults in HIV care were living in 
households with children of unknown HIV status and 
the prevalence of HIV in children tested through this 
approach was significantly higher than from other ‘unse-
lective’ HIV testing approaches within Africa.13 14
The Bridging the GAP in HIV testing and care for Chil-
dren in Zimbabwe (B-GAP) study aims to investigate the 
effectiveness of index-linked HIV testing among children 
aged 2–18 years in Zimbabwe. Testing will use both facil-
ity-based and community-based approaches to address 
the barriers described above. Notably, as well as offering 
facility-based and home-based HIV testing for untested 
children of index adults with HIV, this study will also inves-
tigate a novel approach whereby caregivers can test their 
children using an oral mucosal HIV test. We elaborate on 
the formative research that informed the approaches to 
index-linked HIV testing, study design and methodology, 
analysis and intended study impact. In addition, the study 
will also evaluate the cost-effectiveness and conduct a 
process evaluation to inform factors that will influence 
scalability of this approach in programmatic settings. 
This study speaks strongly to the WHO recommendations 
to develop innovative feasible strategies to reduce the 
burden of undiagnosed HIV among children.12
MEthods
study objectives
The aim of the study was to evaluate the effectiveness of 
index-linked HIV testing in identifying children with HIV 
aged 2–18 years in Zimbabwe. The objectives are to
1. Evaluate the acceptability, uptake and yield of an in-
dex-linked HIV testing strategy for children and ado-
lescents in facility-based and community-based settings.
2. Investigate factors associated with uptake of in-
dex-linked HIV testing and with choice of a certain 
method (clinic-based, community-based provider-de-
livered and community-based caregiver-delivered test-
ing).
3. Investigate linkage to care, retention in care and viro-
logical suppression among children living with HIV 
who are offered community health worker (CHW) 
delivered support in addition to clinic-based care (the 
standard of care).
4. Estimate the cost and calculate the cost-effectiveness of 
index-linked HIV testing for children and adolescents, 
compared with current standard of care.
5. Conduct a process evaluation of the intervention’s im-
plementation, mechanisms of impact and local context 
to inform the components required for sustainability 
and scalability.
Patient and public involvement
Formative research and key considerations for study design
Between May and December 2017, we conducted exten-
sive stakeholder engagement and a situational analysis to 
inform the intervention design with regard to the testing 
strategy. The specific objectives were first to understand 
HIV testing pathways within public healthcare facilities 
and their partnerships with non-governmental stake-
holders; to inform selection of study sites and healthcare 
worker cadres to implement the intervention; and second 
to elicit key stakeholder views on preferences, potential 
limitations and foreseeable obstacles for delivery of index-
linked HIV testing. Results were used to inform the inter-
vention design and preparedness for implementation, as 
well as development of standard operating procedures.
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Interviews were conducted with Ministry of Health and 
Child Care (MoHCC) officials and key informants from 
MoHCC partner organisations that were implementing 
HIV programmes in Zimbabwe. In total, 25 field observa-
tions, 19 site assessments at healthcare facilities across 2 
provinces and 53 in-depth interviews (IDIs) with health-
care providers, community-based organisations, adults 
and adolescents living with HIV and CHWs were under-
taken. These findings will be reported in detail elsewhere; 
however, a summary of how findings informed design is 
shown in table 1.
Formative work was also conducted to inform the 
community-based support intervention for children 
living with HIV delivered by CHW. The research find-
ings, development and design of the community-based 
support intervention will be presented in a separate 
manuscript.
study sites
Zimbabwe has the sixth highest adult HIV prevalence 
globally and approximately 1.3 million people were living 
with HIV in 2017.6 15 The study will be conducted in six 
primary healthcare clinics (PHCs) in Bulawayo (urban) 
and three PHCs in Mangwe district (rural) in Zimbabwe. 
In 2016, Bulawayo had the highest adult HIV prevalence 
(18.7%) in an urban setting, while Mangwe in Matabele-
land South Province has the highest national HIV preva-
lence (22.3%).15 Clinics were purposively selected based 
on (1) the size of the facility so that the target sample size 
could be reached, and (2) their geographical locations 
to allow good accessibility by the study team in rural sites 
(figure 1). HIV clinics in hospitals were excluded due to 
their larger and less well-defined catchment area which 
would make community-based testing and follow-up 
difficult.
Participant recruitment: inclusion and exclusion criteria
All individuals with HIV attending for care at study clinics 
will be screened daily to identify attendees with children 
aged 2–18 living in their household (index). If the index 
attendee is <18 years, they will need to be accompanied by 
a parent or caregiver aged >18 years to provide consent. 
Indices who have children with unknown status or chil-
dren who previously tested HIV negative more than 
6 months ago will be offered HIV testing for their chil-
dren. Being tested more than 6 months ago was included 
as a criterion for offering testing to account for older 
children who may have been horizontally infected. If 
the index consents to having the child or children in the 
household tested, three testing options will be offered: 
(1) testing at the clinic by a healthcare provider, (2) 
home-based testing performed by a healthcare provider 
or (3) at home by the caregiver using a self-test kit.
Table 1 Summary of how formative research informed intervention design
Finding Intervention design
Prevalence of undiagnosed HIV among children is 
heterogeneous across settings and regions.
Study sites were chosen based on an anticipated high prevalence of 
undiagnosed HIV.
Index-linked testing has not been fully implemented due 
to staff shortage at health facilities.
Research staff were hired to support implementation of intervention 
in facilities.
HIV testing services are provided by multiple 
stakeholders across the country with poor coordination 
between stakeholders. This results in duplication of 
services and failure to link individuals accessing services 
through community partners with health facilities.
A collaborative agreement between the research team and the 
MoHCC and its implementing partners conducting HIV testing in 
facilities and communities was established. HIV test kits will be 
provided by the MoHCC and all HIV testing data reported to the 
MoHCC.
User fees are in place for health service provision at the 
urban facilities including HIV testing (US$5 and US$3 
depending on age of child).
For the purpose of this study, user fees will be dropped for all 
children and adolescents undergoing HIV testing in selected 
healthcare facilities
Individuals have to travel long distances to access 
healthcare facilities particularly in rural settings.
A novel HIV testing strategy will be introduced whereby caregivers 
will be given the option to test their children at home using an HIV 
self-test kit, thus eliminating the requirement for caregivers to bring 
children to the healthcare facility for testing.
MoHCC, Ministry of Health and Child Care.  
Figure 1 Map of the selected Bridging the GAP in HIV 
testing and care for children in Zimbabwe sites.
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Demographic details of the index and the children 
will be recorded electronically on tablets by the research 
assistants using Open Data Kit.16 Locator details of the 
household including mobile phone numbers and phys-
ical addresses will be collected for all consenting index 
cases and particularly for community-based HIV testing 
and to ascertain HIV test outcomes among those who opt 
to test their children using a self-test kit. All participants 
will be given a study helpline number to call for further 
information, counselling referrals or support.
hIV testing procedures
HIV testing will be carried out according to national 
guidelines using a serial testing algorithm.17
Clinic-based HIV testing
Caregivers who opt for clinic-based HIV testing of 
their children will be given referral cards on the day 
of screening by a research assistant. HIV testing will be 
performed by routine clinic staff. Research assistants will 
use locator information to follow-up participants who 
have consented to have their child(ren) tested in the 
clinic but have not presented to the clinic within 7 days 
of recruitment. They will make up to three attempts to 
locate the index via telephone or home visit at day 7, 14 
and 21 postscreening.
Community-based HIV testing by a healthcare provider
Caregivers who opt for community-based testing will 
indicate a suitable date for HIV testing on the day of 
screening. A MoHCC implementing partner for commu-
nity-based testing will visit the household to conduct an 
HIV test. If no contact is made on the scheduled visit date, 
the provider will conduct a further two visits to perform 
HIV testing. A test outcome will be recorded once three 
attempts have been made within 30 days of screening.
Community-based HIV testing by the caregiver
Caregivers who opt to use an HIV oral mucosal test 
(OMT) to test their children at home will undergo an 
assessment of guardianship status for each child. Only 
indices who are parents or legal guardians of eligible chil-
dren will be eligible to take an OMT kit. Detailed instruc-
tions on performing an oral HIV test and interpreting the 
test result will be given by research assistants in the clinic 
using an OMT, an instruction pamphlet from the manu-
facturer translated to local languages and demonstration 
videos. The research assistant will complete a brief compe-
tency assessment including a demonstration of how to 
perform the test and how to interpret a set of results 
displayed on pictures by the caregiver. If the caregiver 
fails the competency assessment, they will be asked to take 
up either of the other two testing options. Caregivers who 
successfully complete the competency assessment will be 
provided with a test kit for each eligible child and will be 
instructed to conduct the test within 5 days of screening 
and to keep the used OMT kit. They will be instructed to 
bring each child who tests OMT reactive for HIV to the 
clinic for confirmatory HIV testing as recommended by 
WHO guidelines.18 Written information about confirma-
tory HIV testing services will be provided. Caregivers will 
be followed up to ascertain HIV test outcome either by 
telephone call or home visit within 7 days and their used/
unused OMT test kits will be collected within 21 days of 
screening.
The first 10–15 index cases who select caregiver testing 
in each clinic will undergo supervised caregiver self-
testing to evaluate if there are any problems with care-
givers’ understanding. The parent/guardian will conduct 
the test while a research assistant is present at the home 
on the selected testing date and in parallel the research 
assistant will conduct a rapid blood test as per the 
national HIV testing algorithm.17 During the assessment, 
the research assistant will note any challenges the care-
giver had with completing the test and whether or not 
the caregiver requested assistance from the research assis-
tant. Appropriate changes will be made to the training 
and demonstration practices if necessary.
Linkage to care if HIV positive
Children and adolescents will be told their HIV status 
according to their level of understanding and maturity 
as described by the national HIV testing and counselling 
guidelines.17 All caregivers and children who test HIV 
positive will receive post-test counselling and a written 
referral to their nearest healthcare facility for confirma-
tory HIV testing and linkage to HIV care. For clinic-based 
testing, referrals will be made to the clinic staff respon-
sible for initiating care on the day of testing. For commu-
nity-based testing and caregiver testing, written referrals 
will be made to the nearest/preferred healthcare facility 
and all participants will be followed up by study staff to 
ascertain linkage to HIV care. Study staff will share all 
HIV testing records with the relevant healthcare facility. 
Caregivers of and children who test HIV positive (or are 
identified as known HIV positive but not linked to care) 
will be offered support visits from a CHW at home or at a 
community-based location of their choice conducted at 1, 
3 and 6 months postdiagnosis.
In addition to the above-described testing procedures, 
partners of index cases will be offered HIV testing. This 
will not contribute to study outcomes but will be imple-
mented to ensure the intervention complies with current 
standard of care and WHO recommendations.
outcomes
The primary outcome will be uptake of HIV testing, 
defined as an eligible child having completed an HIV 
test and the caregiver knowing the test result within 30 
days of the HIV test being offered. The HIV test result or 
reasons why a test is not done will be recorded. Secondary 
outcomes for the study will include the preferred HIV 
testing method, HIV yield and prevalence. HIV preva-
lence and yield will be stratified by age group (0–5, 6–10 
and 10–18 years). Additional secondary outcomes will 
be linkage to HIV care and viral load suppression at 12 
months postdiagnosis.
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Cost-effectiveness analysis
The cost-effectiveness analysis aims to determine whether 
index-linked testing in children is a cost-effective strategy 
compared with current standard of care in Zimbabwe; 
passive provider-initiated testing at healthcare facilities. 
Both the full costs of delivering the intervention and 
the incremental costs will be estimated using a provider 
perspective through mixed methods involving a combina-
tion of primarily bottom-up micro-costing, with the use of 
top-down costing when necessary. Costs will be presented 
as follows: (1) Cost per child tested via each of the index-
linked testing modalities; (2) Cost per HIV-positive child 
detected through each of the index-linked testing modal-
ities; and (3) cost per new HIV initiate. The base case 
Cost-Effectiveness Analysis (CEA) will be conducted over 
a lifetime time horizon, annually discounted at the stan-
dard rate of 3%,19 to reflect future costs and effects at 
current value, to estimate the incremental cost effective-
ness ratio, as cost per disability-adjusted life year (DALY) 
averted. A dynamic transmission model will be used to 
estimate the DALYs averted, derived from a combination 
of accessing treatment and the HIV infections averted, 
using parameters extracted from the literature. A sensi-
tivity analysis will be conducted to explore the impact of 
key variables on the results including HIV prevalence and 
geographical location. As there is much debate and uncer-
tainty surrounding recommended C-E threshold values 
for different settings,20 a cost-effectiveness acceptability 
curve will be constructed. The resulting Incremental 
Cost-Effectiveness Ratio (ICER) will be compared against 
different threshold values that are likely to be appropriate 
to the Zimbabwe setting. This analysis will help inform 
MoHCC policy around alternate forms of HIV testing and 
counselling.
Process evaluation
A detailed mixed-methods process evaluation will be 
conducted alongside the delivery of the intervention. The 
process evaluation will be based on the Medical Research 
Council Process Evaluation Framework and will explore 
three core evaluation functions: implementation, mecha-
nisms of impact and context to evaluate the delivery and 
receipt of the intervention, in order to better understand 
what components of the intervention work, for whom and 
under what circumstances.21 The process evaluation data 
will be analysed and written up in order to contribute 
to understanding the study results and to provide guid-
ance for sustainable and scalable implementation of the 
intervention by local health authorities should it prove 
successful. Quantitative indicators for the process evalua-
tion will include staff turnover, record of shortage of test 
kits and supplies and incident reports about facility-based 
and community-based testing from research assistants 
and the project coordinator. Descriptive statistics of these 
indicators will be used to help assess aspects of the inter-
vention’s fidelity, feasibility and acceptability, and to iden-
tify lessons important in informing the replication and 
scale-up of this approach to testing.
Focus group discussions (FGDs) with research assistants 
and FGDs and IDIs with a purposively selected sample of 
indices will be conducted to elicit provider and caregiver 
perceptions and experiences of index-linked HIV testing 
for children at baseline and end line. Sampling for FGDs 
will include a group of caregivers representing index age 
(older vs younger) and sex, HIV testing option, HIV test 
uptake (accepted vs did not accept testing; and whether 
child tested or not) and study site (rural vs urban). We will 
also conduct IDIs with caregivers who had a child test HIV 
positive through index-linked HIV testing at end line.
As testing by caregivers is a novel intervention, the 
acceptability of this method will be explored from 
providers’ and caregivers’ perspectives. IDIs will be held 
with caregivers who selected this option to understand 
how messaging and training for caregiver testing used 
in the competency and accuracy assessments can be 
improved, as well as how testing is performed by care-
givers on their children in their homes. Interviews will 
also be held with index participants who did not select his 
method to understand their concerns.
sample size estimates
Sample size estimations are based on precision of esti-
mates of uptake of index-linked HIV testing. We will 
recruit participants from nine clinics, with an average 
daily adult attendance of 32 per clinic (excluding repeat 
attenders). Over 12 weeks per clinic, we expect to screen 
a total of 5184 HIV-positive index cases at nine clinics with 
children aged 2–18 years (assuming 5 working days a week 
and 30% of adults with HIV have children and adoles-
cents living in the household). Assuming an index refusal 
rate of 35%, and an average of 2 children per house-
hold, we would screen approximately 6739 children and 
adolescents. This sample size provides ±1% precision for 
an estimate of 80% of screened children and adolescents 
taking up HIV testing, with a 95% CI of 79.0%–81.0%. 
Sample sizes for qualitative work will be determined on 
an ongoing basis by study staff until thematic saturation 
has been reached.
Assuming HIV prevalence of 4%, this would yield 215 
children living with HIV eligible for linkage-to-care. This 
sample size provides good precision of ±6% around an 
estimated 80% linking-to-care (n=172) and precision of 
±9% around an estimated 70% with viral suppression at 
12 months out of 85% retained in care (n=102/146).
data analysis
A study flowchart showing total number of index cases 
screened, eligibility of index cases and children in their 
household, proportions of index cases providing consent 
for collection of additional data about themselves and 
the children living in their households will be presented 
(figure 2). Demographic characteristics of index partici-
pants and children and adolescents living in their house-
holds will be summarised using proportions, means and 
SD. The uptake of HIV testing and HIV prevalence strati-
fied by age group (0–5, 6–10 and 10–18 years) and sex will 
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be calculated, and factors associated with uptake of index-
linked HIV testing will be assessed using univariate anal-
ysis. A multivariate logistic regression will be conducted 
to assess factors predictive of uptake/non-uptake of HIV 
testing adjusted for clustering by index case. We will eval-
uate factors associated with the uptake of the preferred 
HIV testing method using multinomial logistic regres-
sion. The proportion of children who tested positive and 
linked to HIV care and the proportion with virological 
suppression will be calculated at 12 months.
study status
The study began recruitment of study participants in 
January 2018. Recruitment is ongoing.
dIsCussIon
There has been a remarkable scale-up of prevention of 
mother-to-child HIV transmission (PMTCT) programmes 
resulting in a decline in numbers of perinatally acquired 
HIV infections.2 However, many children and adoles-
cents with HIV, acquired before PMTCT programmes 
were scaled-up, remain undiagnosed, with diagnosis only 
occurring when they present with advanced disease.6 In 
addition, suboptimal coverage of early infant diagnosis 
within PMTCT programmes results in many HIV-exposed 
children not being identified.2 6 Those who acquire HIV 
postnatally through breastfeeding may also present later 
in childhood. HIV testing is the critical step to accessing 
HIV treatment and high rates of undiagnosed HIV partly 
explain the lower coverage of HIV treatment in children 
and adolescents compared with adults.22
PITC has been recommended by the WHO since 
2007.23 However, this relies on an individual attending 
a health facility. Also, PITC may not be as cost-effective 
a strategy in children as in adults given the lower HIV 
prevalence among children compared with adults. Index-
linked testing is a targeted strategy focusing on testing of 
children at higher risk of HIV infection. If effective, this 
strategy has the potential to be a more cost-effective and 
efficient HIV testing strategy in resource-limited settings. 
Our study will implement both community-based and 
health facility-based HIV testing for children and investi-
gate a novel approach of caregivers testing their own chil-
dren to increase accessibility and uptake of HIV testing.
We believe that community-based strategies in our 
study have the potential to eliminate many of the barriers 
to HIV testing for children and adolescents.14 In a study 
conducted in Malawi, index-linked testing offered to chil-
dren and young people (1–24 years) had higher uptake 
for community (95.5%) when compared with facili-
ty-based (4.5%) testing.14 Enabling caregivers to test their 
children may reduce the burden of client-associated costs 
such as time spent in and getting to facilities for testing 
by clients, provider time, and maintenance and upkeep of 
health facilities. However, most importantly, it allows the 
caregivers to perform the test in the comfort and privacy 
of their homes and empowers them to take responsibility 
for the testing. Another innovation is the use of CHWs to 
perform HIV testing in the community. While a similar 
cadre termed ‘primary care counsellor’ is widely used 
to provide HIV testing in health facilities, HIV testing in 
communities is largely provided by nurses. The CHWs will 
complete a 2-week training in ethics and rapid HIV testing 
as well as on study procedures. If effective, our study 
will provide evidence for use of lower level cadres such 
as community health workers to offer and perform HIV 
testing as advocated by the WHO.12 There is evidence to 
show that the use of lower level cadres can reduce cost of 
staffing for the government and may improve cost-effec-
tiveness of community-based approaches when compared 
with traditional facility-based HIV testing.24
Furthermore, the study also addresses linkage to care, 
initiation of ART and adherence through a commu-
nity-based support intervention. It is crucial that any 
HIV testing intervention addresses these steps in the 
continuum of HIV care to ensure maximum benefits (ie, 
reduced morbidity and onward transmission).
Potential challenges include low uptake of the inter-
vention, lost-to-follow-up of clients once they have agreed 
to have their child tested and finding clients who have 
opted for home-based testing. Within our study, user fees 
for HIV testing were dropped. This has implications for 
the generalisability of our findings in settings where user 
fees are in place and may act as a barrier to uptake of HIV 
testing services. Similarly, our study findings may not be 
generalisable to other settings as contextual factors may 
affect uptake of the intervention. It is important to note 
that in parallel to evaluation of uptake and yield of index-
linked HIV testing, we will conduct a detailed process 
evaluation to explore the implementation, mechanisms 
of impact and contextual factors affecting the delivery 
and acceptability of this intervention, which will help 
Figure 2 Index-linked HIV testing participant flow.
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inform sustainability and scale-up should it prove effec-
tive. Another limitation is that other HIV testing inter-
ventions will be implemented in our study settings at the 
same time. However, detailed recording of other HIV 
testing interventions will be part of the process evalua-
tion. This will help with understanding how other HIV 
testing interventions interact with each other and index-
linked testing.
Ethics and dissemination
Ethical approval was sought and granted by the Medical 
Research Council of Zimbabwe (MRCZ), the London 
School of Hygiene and Tropical Medicine ethics 
committee and the Institutional Review Board of the 
Biomedical Research and Training Institute.
Study progress and findings will be reported annually 
to MRCZ and feedback meetings will be held quarterly 
with the health directorates of the two study sites. Results 
of interim data analysis will be presented at national and 
international research meetings and conferences. Results 
will also be prepared for publication in international 
peer-reviewed scientific journals and disseminated to 
study communities at the end of study. A detailed dissem-
ination plan to inform scale-up will be developed for 
implementation.
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